Which Drugs have Riskiest Profiles? Safety Score a…

Which Drugs have Riskiest Profiles? Safety Score and Cost Burden Analysis. rxview.adverahealth.com/safety-score-c… Via @AdveraHealth #pharma

Medicaid Rx Drugs: Most costly drugs, highest volu…

Medicaid Rx Drugs: Most costly drugs, highest volume, more interesting info. goo.gl/PBSsrq #pharma Via @KaiserFamFound

Drug Prices: New CMS guidance to State Medicaid ag…

Drug Prices: New CMS guidance to State Medicaid agencies on value-based drug prices, negotiations. goo.gl/RktmbH #pharma

RT @SarahKarlin: $AMGN wins at Federal Circuit in…

RT @SarahKarlin: $AMGN wins at Federal Circuit in #biosimilar case v. Apotex: politicopro.com/health-care/wh… #pharma

Trends in adverse drug event reporting by consumer…

Trends in adverse drug event reporting by consumers, physicians, pharmacists, other HCPs. fda.gov/Drugs/Guidance… #FDA #pharma

Medicare Part D and dual eligibles: new OIG report…

Medicare Part D and dual eligibles: new OIG report on Part D drug plans formularies. oig.hhs.gov/oei/reports/oe… #pharma

Drug Development, Drug Pricing Dynamics, Supply Ch…

Drug Development, Drug Pricing Dynamics, Supply Chain: Overview by MedPAC medpac.gov/documents/fact… #pharma #drugs #biotech #pharmacy

Medicare Prescription Drug Spending: Overview by M…

Medicare Prescription Drug Spending: Overview by MedPAC. medpac.gov/documents/fact… #pharma #drugs #biotech

Ways to Improve Medicare Part D Prescription Drug…

Ways to Improve Medicare Part D Prescription Drug Benefit. goo.gl/EkQZ1R Via @medicarepayment #pharma

Medicare, Oncology, and Drugs: MedPAC deck on Part…

Medicare, Oncology, and Drugs: MedPAC deck on Part B payment reforms. goo.gl/PJQGra #cancer #biotech #pharma